Match Document Document Title
9040078 Use of lipid conjugates in the treatment of diseases of the nervous system  
The invention provides a method for treating a subject suffering from a disease of the central nervous system which is associated with an inflammatory response, including, inter alia, multiple...
9040581 Methods of treatment using D-serine  
Methods of treatment using D-serine to target brain cells expressing GluN3 subunit-containing triheteromeric NMDARs are disclosed. The methods include inhibiting calcium ion uptake by brain cells,...
9034319 Methods of treating cancer of the central nervous system  
A method of treating a cancer of the central nervous system in a subject in need thereof is provided. The method comprising administering to the subject a therapeutically effective amount of an...
9029410 Pharmaceutical compositions for the treatment of movement disorders  
A pharmaceutical composition, medical food, dietary supplement or micronutrient for the treatment of a movement disorder comprising an NMDAR agonist or partial agonist as active ingredient therein...
9018237 Methods for improved wound closure employing olivamine and endothelial cells  
The present disclosure relates to compositions for and methods of improving wound healing, including compositions for and methods of treating chronic wounds, and compositions for the inhibition...
8999296 Method of detecting bladder cancer  
Provided is a sensitizing detection agent of an oral or intravenous administration type which enables the detection of bladder cancer with a higher sensitivity without causing pain to the patient....
8993610 Methods and compositions for increasing the anaerobic working capacity in tissues  
Provided are compositions comprising beta-alanylhistidine peptides and/or beta-alanines, and methods for administering these peptides and amino acids. In one aspect, the compositions and methods...
8987244 Preventing and/or treating cardiovascular disease and/or associated heart failure  
Methods are provided for reducing copper values for, by way of example, treating, preventing or ameliorating tissue damage such as, for example, tissue damage that may be caused by (i) disorders...
8980307 Compositions and methods for the sustained release of beta-alanine  
Methods and compositions are provided for increasing the anaerobic working capacity of muscle and other tissues. Also provided are compositions formulated for the sustained release of free...
8962684 Antioxidant composition  
Disclosed is a stable and safe antioxidant composition which can be used routinely. Specifically disclosed is an antioxidant composition which contains one or more compounds selected from the...
8937100 Cosmetic composition containing calcium citrate and N-acylated aminoalcohol derivative  
Cosmetic compositions comprising calcium citrate and at least one N-acylated aminoalcohol according to formula (I). Provided is a method of treating aged skin, comprising topically applying to the...
8933057 Crystallization method and bioavailability  
Preparation, in-vitro and in vivo characterization of novel forms of (1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl) phosphonic acid, suitable for pharmaceutical compositions in drug delivery...
8927532 Therapeutic agent and diagnostic agent for mitochondrial dysfunction brain diseases  
To provide a therapeutic agent and a diagnostic agent for mitochondrial dysfunction brain diseases including cerebral infarction as a representative. A therapeutic agent for a mitochondrial...
8916502 Agent for improving lawn grass qualities  
An agent for improving lawn grass quality, which is excellent in promoting dwarfing of lawn grass, making the stem sturdy, increasing the leaf count, and improving greenness, is provided. An agent...
8901039 Use of photosynthetic pigment stabilizing agents to regulate ripening and quality in fruits and vegetables  
Methods and compositions to temporarily delay the ripening, maturation, senescence and pathogen infection of produce such as fruits, vegetables and ornamental plants are provided. The methods...
8895473 Aqueous composition for raising antioxidant enzyme activities and enhancing cell membrane-stability in plants exposed to low temperature  
Present invention provides an aqueous composition made from selected biochemical substances that will help with the low temperature tolerance of plants and thus to avoid “chilling injury” and to...
8889594 Agent for improving good rice seedling growth  
There is provided an agent for improving the growth of seedlings, having effects of raising healthy rice seedlings, such as increase of the tillering number, increase of root weight, enhancement...
8883148 Prevention of joint destruction  
A method for treating, preventing or reducing the risk of joint destruction in a subject who suffers from a joint or musculoskeletal disease. The method comprises administering a histone...
8846039 Method for ameliorating pruritus  
A method for preventing, treating, or ameliorating pruritus caused by skin, mucosa, or systemic disorder. The method comprises administering to a subject with pruritus or topically applying to an...
8846759 Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis  
The present invention relates to the use of a low-caloric high-protein nutritional composition for use in the prevention or treatment of a disease or condition in a mammal, which involves muscle...
8815919 Oxadiazole derivatives  
The invention relates to oxadiazole compounds of formula I. The compounds are useful e.g. in the treatment of autoimmune disorders, such as multiple sclerosis.
8809394 Tranexamic acid formulations  
Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
8809311 Nutritional supplements  
A process for improving the health of a subject, the process comprising orally administering a composition comprising hydroxytyrosol to the subject to provide the subject with a daily dose of...
8796331 Methods of treatment and pharmaceutical composition  
The invention relates a pharmaceutical composition comprising a combination of: (i) the AT 1-antagonist valsartan or a pharmaceutically acceptable salt thereof; and(ii) a NEP inhibitor or a...
8796315 Methods for improved wound closure employing olivamine and human umbilical vein endothelial cells  
The present disclosure relates to compositions for and methods of improving wound healing, including compositions for and methods of treating chronic wounds, and compositions for the inhibition...
8790712 Constitutional function-improving agents  
The present invention is drawn to a method of inducing thymocyte proliferation in a vertebrate animal with an impaired immune system comprising administering δ-aminolevulinic acid or a salt...
8791160 Tranexamic acid formulations  
Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
8778410 Oral or enteral composition useful for recovery of physical functions  
The present invention provides an oral or enteral composition incorporating not only BCAA but other nutrients to be conducive to comprehensive recovery from fatigue, and improvement in total...
8778999 Non-steroidal anti-inflammatory ophthalmic compositions  
The disclosure provides compositions and systems for topical ophthalmic application, which include an aqueous mixture of bromfenac and flowable mucoadhesive polymer, for treating inflammation and...
8778996 Method of treating a human being for a class of neurological defects and seizure disorders  
The invention involves various embodiments of a method for treating a human being for a condition associated with (1) seizures, myoclonic seizures, epilepsy, refractory epilepsy, hyperkinetic...
8765794 Compositions and methods for wound care  
The present disclosure relates to compositions for and methods of repairing the stratum corneum, compositions and methods for inhibiting excessive transepidermal water loss, compositions for and...
8759396 Use of aminolevulinic acid and derivatives thereof  
The invention provides the use of a photosensitizer which is 5-aminolevulinic acid (5-ALA) or a derivative (e.g. an ester) of 5-ALA, or a pharmaceutically acceptable salt thereof, in the...
8735451 D-serine transporter inhibitors as pharmaceutical compositions for the treatment of visual system disorders  
The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors and therapeutic methods using such pharmaceutical compositions in methods for the treatment...
8734837 Enhancement of development of oviparous species by in ovo feeding of enteric modulators  
The development and growth of oviparous species such as birds is enhanced by in ovo administration of an enteric modulator such as HMB. The enteric modulator is administered into the amnion, where...
8722669 Compounds and methods of treating ocular disorders  
A method of treating an ocular disorder in a subject associated with aberrant all-trans-retinal clearance in the retina, the method comprising administering to the subject a therapeutically...
8715737 Method to make porous materials and their applications  
The present invention relates a method to make porous materials which are useful in pharmaceutical, medicine, industry, and agriculture. The most advantage of the porous materials is to provide...
8710040 Pharmaceutical composition comprising gabapentin or an analogue thereof and an α-aminoamide and its analgesic use  
There is disclosed a pharmaceutical composition comprising gabapentin or an analogue thereof (pregabalin or tiagabine) and an α-aminoamide and its analgesic use. A synergistic effect of the...
8703809 Combination products  
The invention concerns the combinations of an mGluR modulator, e.g. an mGluR5 modulator and at least one of L-dopa, a dopamine modulator, e.g. a dopamine agonist, a dopa decarboxylase inhibitor or...
8703211 Agent and method for treating cancer comprising strontium, amino acid(s) and mineral agent(s)  
The invention relates to the treatment and prophylaxis of cancer. In particular, the invention relates to a pharmaceutical agent comprising strontium, amino acid(s) and mineral element(s), and its...
8697750 Oil-in-water type emulsion skin cosmetic  
An oil-in-water type emulsion skin cosmetic which can be spread on skin easily. The formulation can contain glycerin at a high concentration or a formulation containing a combination of glycerin...
8686040 Method for treating anal pruritis and other perianal disorders  
The invention relates to methods and compositions for the treatment of pruritis ani and other perianal disorders. There are currently few treatments for these conditions, many of which have...
8680051 Method of ameliorating symptoms of type 1-diabetes using GABA related compounds and GLP-1/exendin-4 compounds  
A composition for the prevention or treatment of type I diabetes in a subject, said composition comprising a GABAergic and incretin exemplified by GABA and GLP-1/Ex4. These are optionally provided...
8673977 Choline salts of succinic acid for the treatment of depression, anxiety, schizophrenia, sleep disorder, and epilepsy  
The present invention relates to compositions and methods for treatment of depression, anxiety, schizophrenia, sleep disorder, or epilepsy comprising monocholine salt of succinic acid of a formula...
8668921 Lipase inhibitors  
The present invention provides lipase inhibitors containing dimers of flavan-3-ols derived from teas as well as foods and beverages and medicines containing said inhibitors. More specifically, the...
8658694 Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same  
Buffer solutions for pharmaceutical preparations that have bactericidal activity preferentially against gram negative bacteria are provided. The buffers have a pH of greater than about 10 or less...
8653138 Calcium salts of compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents  
The present invention relates to calcium salts of compounds of the general formula (I) whereinX is selected from the group consisting of CH2, S, or O;D is O or S;R8 is hydrogen or alkyl;E is an...
8652496 Biocides and apparatus  
A biocide is formed by mixing at least one of ammonium sulfamate and ammonium carbamate with an aqueous solution of a hypochlorite oxidant at a molar ratio of ammonium to hypochlorite of at least...
8653137 Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same  
Buffer solutions for pharmaceutical preparations that have bactericidal activity preferentially against gram negative bacteria are provided. The buffers have a pH of greater than about 10 or less...
8653135 Alternating sympathomimetic therapy for the treatment of respiratory aliments  
A combination of dosage units for alleviating respiratory ailments and a method of alleviating respiratory ailments which uses this combination of dosage units. The dosage units comprise one or...
8653136 Compositions based on amino acids for improving the myocardial ventricular function in patients suffering from diabetes  
Compositions based on amino acids are described, for improving the myocardial ventricular function in patients suffering from diabetes, particularly but not exclusively II type diabetes. The...